J&J: Now Master Over Mentor (MNT, JNJ)

Health and Healthcare

Published: December 1, 2008 8:21 am

Last Updated: April 28, 2020 12:15 am

If you thought that high-premium buyouts or M&A was dead, that is not the case in at least some opportunities. Mentor Corp. (NYSE: MNT) has just secured a major premium buyout this Monday morning with Johnson & Johnson (NYSE: JNJ) as the suitor.

Mentor will be acquired for approximately $1.07 billion in a cash tender offer valued at $31.00 per share.

Mentor Corporation is in the development, manufacturing, licensing, andmarketing of various products for the aesthetic and general surgerymarkets. The company will operate as a stand-alone business unit underJ&J’s ETHICON, Inc. unit, a provider of suture, mesh and otherproducts for a wide range of surgical procedures. One of Mentor’soperations it is best known for is its breast augmentation andreconstruction operations.

This is actually a near-100% buyout premium. Shares of Mentor closedat $16.15 on Friday, and the 52-week trading range is $13.33 to $40.82.

Jon C. Ogg
December 1, 2008

Want to Retire Early? Start Here ^(Sponsor)

Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?

Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.

Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.